Forging new care pathways for menopause
Over 75% of women experience menopause symptoms
Yet 73% of women report that they've never received treatment for menopause, and many studies point at the most common treatment, Hormone Replacement Therapy, having more risks than benefits.
We are collaborating with Imperial College London to build neurotechnology solutions for women suffering from the most common and severe menopause symptoms.
Across its product portfolio, Samphire maintains active clinical and research partnerships with clinicians and academic institutions across Europe, North and South America, and South East Asia, and develops alongside other leaders in the field. If you are a clinician with an active or growing practice treating the symptoms of menopause, please get in touch.
At the core of our mission is to design with - and not just for - all women. If this resonates, or if you wish to take part in one of our various clinical trials around the world, please get in touch.